In the downregulated DEGs, the enriched pathways were related to pathways of neurodegeneration in multiple diseases [46], pathways in cancer, microRNAs in cancer [47], thermogenesis [48,49], diabetic cardiomyopathy [50], and renin secretion [51,52,53]. This evidence concerns the gene REN and cancer.